Abstract:Podophyllotoxin is a naturally occurring cyclolignan isolated from rhizomes of Podophyllum sp. In the clinic, it is used mainly as an antiviral; however, its antitumor activity is even more interesting. While podophyllotoxin possesses severe side effects that limit its development as an anticancer agent, nevertheless, it has become a good lead compound for the synthesis of derivatives with fewer side effects and better selectivity. Several examples, such as etoposide, highlight the potential of this natural product for chemomodulation in the search for new antitumor agents. This review focuses on the recent chemical modifications (2017–mid-2023) of the podophyllotoxin skeleton performed mainly at the C-ring (but also at the lactone D-ring and at the trimethoxyphenyl E-ring) together with their biological properties. Special emphasis is placed on hybrids or conjugates with other natural products (either primary or secondary metabolites) and other molecules (heterocycles, benzoheterocycles, synthetic drugs, and other moieties) that contribute to improved podophyllotoxin bioactivity. In fact, hybridization has been a good strategy to design podophyllotoxin derivatives with enhanced bioactivity. The way in which the two components are joined (directly or through spacers) was also considered for the organization of this review. This comprehensive perspective is presented with the aim of guiding the medicinal chemistry community in the design of new podophyllotoxin-based drugs with improved anticancer properties.

Resources of Anti-tumour Active Podophyllotoxin Analogues

Synthesis of New Spin Labeled Derivatives of Podophyllotoxin As Potential Anticancer Agents

Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.

Podophyllotoxin, a medicinal agent of plant origin: past, present and future

Synthesis And Evaluation Of New Podophyllotoxin Derivatives With In Vitro Anticancer Activity

Synthesis and Evaluation of Novel Podophyllotoxin Derivatives As Potential Antitumor Agents.

Review on Biosynthesis of Podophyllotoxin

Insight Into the Molecular Mechanism of Podophyllotoxin Derivatives as Anticancer Drugs

Advances of podophyllotoxin and its derivatives: Patterns and mechanisms

Podophyllotoxin: History, Recent Advances and Future Prospects

Synthesis and Biological Evaluation of New 4Β-Anilino-4′-o-demethyl-4-desoxypodophyllotoxin Derivatives As Potential Antitumor Agents

Podophyllotoxin: Recent Advances in the Development of Hybridization Strategies to Enhance Its Antitumoral Profile

Production of podophyllotoxin from Podophyllum hexandrum: a potential natural product for clinically useful anticancer drugs

Challenges and potential for improving the druggability of podophyllotoxin-derived drugs in cancer chemotherapy

Podophyllotoxin Derivatives: Current Synthetic Approaches for New Anticancer Agents

Synthesis and anticancer activity of new derivatives of podophyllotoxin

Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020)

Synthesis and antitumor activity of new derivatives of podophyllotoxin

Synthesis of Novel Spin Labeled Analogues of Podophyllotoxin Glycoside

Synthesis and Biological Evaluation of 4Β-N-acetylamino Substituted Podophyllotoxin Derivatives As Novel Anticancer Agents.